Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Fei Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical …. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B Surface Antigens, Coinfection, Hepatitis B virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases (2021-2023), Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Functional cure of hepatitis B virus (HBV) is an optimal treatment goal for chronic hepatitis B, with the loss of hepatitis B surface antigen (HBsAg) being a crucial indicator. However, the adequacy of HBsAg loss for evaluating functional cure of HBV in patients co‐infected with HBV/human immunodeficiency virus (HIV) remains controversial. In this study, we measured HBV pregenomic RNA (pgRNA), a potential biomarker that correlates with covalently closed circular DNA, in the frozen plasma of 98 patients with HBsAg loss from a large HIV/HBV co‐infection cohort in Guangzhou, China. HBV pgRNA was still detected in 43.9% (44/98) of the patients, suggesting active HBV replication in individuals with HBsAg loss. Our observations imply that HBsAg loss may not be a reliable predictor of HBV functional cure in cases of HIV/HBV co‐infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease, Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Guangzhou Medical Research Institute of Infectious Diseases, Institution of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Feng Li, Linghua Li
Förderung
- Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases (2021-2023)
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Gu, F., Zeng, K., Lan, X., He, Y., Li, F., Tang, X., Hu, F., & Li, L. (2024). Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss. Journal of Medical Virology. https://doi.org/10.1002/jmv.29762
Vancouver
Gu F, Zeng K, Lan X, He Y, Li F, Tang X, et al. Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss. Journal of Medical Virology. 2024. doi:10.1002/jmv.29762
BibTeX
@article{Gu2024,
author = {Gu, Fei and Zeng, Kun and Lan, Xianglong and He, Yaozu and Li, Feng and Tang, Xiaoping and Hu, Fengyu and Li, Linghua},
title = {Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29762}
}
EUVIMED